biotech technology nasdaq 100 stocks

Biotech, Technology, And NASDAQ 100 All Breakout – S&P 500 Back To 2,880?

Subscribe to receive this FREE daily commentary directly in your email

[widget id=”text-23″]

Biotech, Technology, And NASDAQ 100 All Breakout – S&P 500 Back To 2,880?

Stocks were in rally mode again after a better than expected job report boosted the S&P 500 by about 1.5 percent. Any hesitation I have had over the past couple of day seems to indicate that the market, technology, and biotech stocks have now broken out, and that means they may have more upside potential from here.

[widget id=”text-19″]

[widget id=”text-16″]

Let Michael help you! Have questions? Let Michael help you find the answer. Sign-up and get two weeks free: Watch the latest video: Market Surges Breakouts All Over

S&P 500 A Rise Back To 2,880

The S&P 500 is approaching the upper bound of the 2016 lows/Brexit trend line. When the index crossed over the trend back in late December, it resulted in the index surging all the way to 2,880. I think the same thing might happen again this time, as the fundamentals of the economy, the job market, and earnings continue to look very strong.

S&P 500

[widget id=”text-23″]

Biotech Stocks

The NASDAQ biotech ETF cleared two extremely critical levels over the past two days,  resistance at $111.50, and then again today $113.70. That could be a sign the ETF is set to rise all the way back to $119.25.

biotech

We see a similar confirmation in the iShares Biotech ETF (XBI) as well, with the potential for to rise to roughly $98.

One can see well the winners outweigh the losers, with only 2 of the top 25 stocks down.

biotech

[widget id=”text-22″]

Technology Stocks

Technology names broke out as well with the shares Technology ETF (XLK) soaring as well, quickly clearing the resistance level at $69.25.

technology

In fact, like the biotech stocks, the distribution of the technology sector is heavily favored to the winners, with only three stocks lower on the day.  technology

[widget id=”wordads_sidebar_widget-41″]

Microsoft

Microsoft has cleared resistance at $95.70 and has made a new all-time high.

microsoft

Unlock Deeper Insights with Exclusive Member-Only Video Content on The Market Chronicles YouTube Channel – Just $34.99/Month

[youtube-feed feed=7]

Netflix

Netflix shares have broken out from its two day period of consolidation.

netflix

Nvidia

Nvidia shares have also broken above its downward trend as well. My guess is thing can run towards $260.

nvidia

Alphabet

Alphabet shares appear to be playing fill the gap and could make a run towards $1200

alphabet

[widget id=”wordads_sidebar_widget-41″]

Nasdaq 100

Finally, the Nasdaq 100, has broken out.

nasdaq 100

That is it for a Friday.

[widget id=”wordads_sidebar_widget-41″]

[widget id=”text-22″]

Mott Capital’s Reading The Markets – An In-depth Global Macro Stock Market Commentary – In Video Format – See How Michael Dissects The Markets

Just $200 Per Year – Get Your Free 2 Week Trial

Recent Videos:

Market Surges Breakouts All Over

Roku Borrow Rate Surge, Biotech Fakeout?

Tech And Biotech Look Weak, Plus Subscriber Mailbag

What The Heck Happened

Breaking Down Acadia’s Results, Exploring Trends In Chips Stocks

Stocks In Rally Mode, More To Come

Crazy Market Reaction Following Fed Minutes, Plus Subscriber Mail Bag

Subscriber Mailbag, Plus Market Rundown

Free Articles Written By Mike:

Facebook Seen Rising 20% Defying Skeptics

Roku Shares Could Fall 50% Further

Why Micron’s Stock Bulls May Be Wrong

Why Bank Stocks Are Ready for a Short-Term Pullback

3 Under The Radar Stocks That Could Soar 30%

Why Home Depot May Plunge 20% Off Its Highs

Why Biotech Stocks Face Steep Declines Ahead

Netflix Stock Is Poised For An 11% Plunge

Why Salesforce’s Record Stock Gains May Not Last

4 Red Flags For Technology Stocks

Biotech Stock Nektar May Be Ripe For A Sharp Pullback

Macy’s May Fall 18% as Option Traders Turn Bears

Micron May Rise 12% As Analysts Grow More Bullish

Why Amazon’s Stock May Continue To Outperform Alibaba’s

AMD May Fall 17% as Bearish Option Volume Soars

Join our 2,629 Daily Subscribers And Get This Commentary In Your E-Mail! Subscribe

-OR-

[vc_tweetmeme type=”follow” follow_user=”michaelmottcm” show_followers_count=”true” large_button=”true”]

Photo credit via Flickr

Michael Kramer and the clients of Mott Capital own shares of GOOGL NFLX

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future.

© 2018 Mott Capital Management, LLC.  Use, publication or reproduction in any media prohibited without the permission of the copyright holder.

Tags: #sp500 #incyte #nektar #bitoech #technology #stocks #alkermes #costco #instacart #anlylam #nektar #incyte #nvidia 

 

 

 

Add your email to The Market Chronicles' growing list of daily readers. A FREE market commentary on the trading day's most critical and least apparent events!

Add your email to The Market Chronicles' growing list of daily readers. A FREE market commentary on the trading day's most critical and least apparent events!

Subscribe to receive this FREE daily commentary directly in your email

This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.